Related Experiment Videos
Chromosome abnormalities in juxtaglomerular cell tumors
Petter Brandal1, Lill-Tove Busund, Sverre Heim
1Department of Cancer Genetics, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway.
Cancer
|June 22, 2005
Summary
Juxtaglomerular cell tumors (JGCTs) have specific genetic alterations. Gain of chromosome 10 and loss of chromosomes 9 and X may drive JGCT development.
Area of Science:
- Nephrology
- Oncology
- Genetics
Background:
- Juxtaglomerular cell tumors (JGCTs), or reninomas, are rare kidney tumors.
- While typically benign, malignant behavior and fatalities have been reported.
- Cytogenetic characteristics of JGCTs remain largely unknown.
Observation:
- The first karyotype of a JGCT was reported.
- Comparative genomic hybridization (CGH) and interphase fluorescence in situ hybridization (IP-FISH) were performed on two JGCTs.
- Tumors were also analyzed via electron microscopy and immunohistochemistry.
Findings:
- Karyotypic analysis revealed complex aneuploidies in the first tumor.
- IP-FISH confirmed karyotypic findings for Tumor 1; Tumor 2 showed specific chromosomal abnormalities including trisomy for chromosomes 4 and 10, and monosomy for chromosomes 9 and X.
- CGH identified gain of chromosomes 10 and 20 in Tumor 1, and gain of chromosomes 4 and 10 with loss of chromosomes 9, X, and 11q in Tumor 2.
Implications:
- Specific chromosomal gains (chromosome 10) and losses (chromosomes 9, X, and 11q) are implicated in JGCT pathogenesis.
- These findings provide novel insights into the molecular mechanisms underlying JGCT development.
- Understanding these genetic events may aid in future diagnostic and therapeutic strategies for JGCTs.